(Adds further details on the placement offer in paragraphs 2-6)
March 13 (Reuters) - Australia's Syrah Resources (SYR) said on Wednesday it would raise A$98 million ($64.73 million) through a placement and an entitlement offer for funding its Balama graphite operations in Mozambique and its U.S.-based Vidalia project.
Syrah's largest shareholder and the country's top pension fund AustralianSuper have agreed to the conversion of a 5-year unsecured convertible note issued in June 2019 and December 2023 into fresh shares in the lithium miner, it said in a statement.
AustralianSuper had committed to subscribing for all shares under the placement and taking up its full pro-rata entitlement in the institutional entitlement offer, the company said.
The placement would be at a fixed price of A$0.55 per new share, which represented a discount of 19.1% to stock's last closing price on March 12.
The company said it had agreed with AustralianSuper to the conversion of series 1 and 3 notes into new shares at a revised conversion price of A$0.6688 per share.
The company added that AustralianSuper's shareholding would increase to no more than 31.9% post the completion of funding round, from around 17.8% earlier.
Around 178.2 million new shares would be issued under the placement and entitlement offer, Syrah said.
($1 = 1.5140 Australian dollars)
- Forums
- ASX - By Stock
- SYR
- News: SYR UPDATE 1-Australia's Syrah Resources to raise $65 mln for Mozambique, US projects
SYR
syrah resources limited
Add to My Watchlist
1.96%
!
26.0¢

News: SYR UPDATE 1-Australia's Syrah Resources to raise $65 mln for Mozambique, US projects
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
26.0¢ |
Change
0.005(1.96%) |
Mkt cap ! $270.9M |
Open | High | Low | Value | Volume |
25.5¢ | 27.3¢ | 25.5¢ | $634.3K | 2.391M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 379430 | 26.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
26.5¢ | 40672 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 379430 | 0.260 |
9 | 238069 | 0.255 |
16 | 483863 | 0.250 |
13 | 503263 | 0.245 |
22 | 860417 | 0.240 |
Price($) | Vol. | No. |
---|---|---|
0.265 | 40672 | 5 |
0.270 | 144245 | 2 |
0.275 | 628178 | 11 |
0.280 | 177739 | 6 |
0.285 | 418600 | 6 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
SYR (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online